Phase 3 Study of OTO-201 in Acute Otitis Externa
Completed · Phase 3 · Has a placebo group
Conditions studied: Acute Otitis Externa, Swimmer's Ear
In brief
This is a prospective, randomized, double-blind, sham-controlled, multicenter, Phase 3 study in which eligible subjects with acute otitis externa (AOE) will be randomized to receive a single administration of either 12 mg OTO-201 or Sham-Control (empty syringe) to the external auditory canal of the affected ear(s).
Key facts
- Study ID
- NCT02801370
- Run by
- Otonomy, Inc.
- People needed
- 262
- Starts
- 2016-06-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2020-10-19
Who can join
Age: 1 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Call Otonomy call center for trial locations — San Diego, California, United States
- Call Otonomy call center for trial locations — Saskatoon, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.